Screener
Edgewise Therapeutics, Inc. EWTX Invested capital
Discontinued — last reported Q1 '26
Invested capital at other companies
Other financials
Where this comes from
Calculated from Edgewise Therapeutics, Inc.’s reported figures.
The source filing: Edgewise Therapeutics, Inc.’s 10-Q, filed May 7, 2026. Open the filing →
- Filed
- May 7, 2026, 8:09 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001104659-26-056713
FAQ
- What is Edgewise Therapeutics, Inc.'s invested capital?
- Edgewise Therapeutics, Inc. (EWTX) reported invested capital of $463.79M in Q1 2026.
- How has Edgewise Therapeutics, Inc.'s invested capital changed year-over-year?
- Edgewise Therapeutics, Inc.'s invested capital increased by 20.7% year-over-year, from $384.36M to $463.79M.
- What is the long-term trend for Edgewise Therapeutics, Inc.'s invested capital?
- Over 3 years (2022 to 2025), Edgewise Therapeutics, Inc.'s invested capital has grown at a 12.2% compound annual growth rate (CAGR), from $329.13M to $465.1M.
- What does invested capital mean?
- Total debt plus shareholders' equity minus cash, at the quarter end. The capital actually put to work in the operating business — the denominator of return on invested capital (ROIC).
Ask your AI about Edgewise Therapeutics, Inc.'s invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude